Accelerating Assessment of Novel CNS Therapies with Real World Objective Data
Cumulus Neuroscience
Cumulus exists to reduce uncertainty in neuroscience.
For too long, CNS drug development has been hampered by translational challenges, a lack of biomarkers, overlapping symptoms which complicate patient stratification, and day-to-day variation in neurocognitive function and data noise which compromise accurate measurement.
Research Partners
The NeuLogiq® Platform was Designed for use in CNS Clinical Studies in Collaboration with 10 Top Pharma Companies.
NeuLogiq provides frequent, reliable in-clinic and at-home longitudinal monitoring of discrete brain functions.
Designed for Patients
Easy-to-use measurement tools that patients want to engage with.
Built for Researchers
Reliable, repeatable and scalable brain function data you can trust.
Made for Real-World Studies
Engaging multi-modal assessments for use in clinic or at home, unified in one platform.
Accessible
Overcome accessibility issues with a low-burden, engaging platform that makes clinical trials more accessible, improving overall experience and trial participation.
Data Rich
Get deep insights from multi-modal digitised assessments of objective and sensitive measures, including endpoints that are meaningful to patients.
Scalable
Remove limitations with non-invasive, repeated objective measures of target engagement and treatment effects in clinic or at home, on a single platform.
Optimised Trials
Achieve more data per participant, enabling the powering of smaller studies, and earlier decision making, reducing trial costs.
Funders










